AI to transform all processes in drug development by 2026, predicts CPHI Report
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
SÜDPACK customers also benefit when it comes to processing PharmaGuard
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
40,000 visitors and representatives of more than 80 countries set to visit the show
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Subscribe To Our Newsletter & Stay Updated